Increased rate of brain metastasis with trastuzumab therapy not associated with impaired survival. [electronic resource]
Producer: 20031106Description: 114-9 p. digitalISSN:- 1526-8209
- Adult
- Aged
- Aged, 80 and over
- Antibodies, Monoclonal -- administration & dosage
- Antibodies, Monoclonal, Humanized
- Antineoplastic Agents -- administration & dosage
- Bone Neoplasms -- drug therapy
- Brain Neoplasms -- drug therapy
- Breast Neoplasms -- drug therapy
- Case-Control Studies
- Female
- Humans
- Middle Aged
- Neoplasm Metastasis
- Ohio -- epidemiology
- Prevalence
- Receptor, ErbB-2
- Survival Analysis
- Trastuzumab
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.